Merge revenues grow during second quarterConnectivity and PACS firm Merge Technologies reported preliminary results for its second quarter that will be below analysts’ expectations, according to the company. The Milwaukee, WI-based vendor
Connectivity and PACS firm Merge Technologies reported preliminary results for its second quarter that will be below analysts expectations, according to the company. The Milwaukee, WI-based vendor expects revenue to be approximately $2.8 million, a 47% increase compared with the $1.9 million reported in the same period last year. Merge anticipates a net loss of 8 cents to 11 cents a share for the quarter (end-June). The company had a net loss of 12 cents per share in the same period in 1998.
In other Merge news, the company has installed its 275th MergeWorks DICOM clinical imaging network in the U.S. Merge began shipping MergeWorks in the U.S. in 1996. Earlier this year, Merge began offering MergeWorks in Europe, and the company has installed networks at five European sites. In the second quarter, the firms systems solutions division posted a 70% increase in revenue compared with the same period in 1998.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.